| Index | — | P/E | — | EPS (ttm) | -1.18 | Insider Own | 4.10% | Shs Outstand | 33.37M | Perf Week | 0.38% |
| Market Cap | 7.41B | Forward P/E | 49.28 | EPS next Y | 4.51 | Insider Trans | -1.07% | Shs Float | 32.63M | Perf Month | -0.30% |
| Enterprise Value | 7.01B | PEG | — | EPS next Q | 0.85 | Short Float | 5.56% | Perf Quarter | 1.70% | ||
| Income | -40.00M | P/S | 8.66 | EPS this Y | 220.43% | Short Ratio | 6.14 | Perf Half Y | 2.35% | ||
| Sales | 856.00M | P/B | 6.77 | EPS next Y | 55.03% | ROA | -3.12% | Short Interest | 1.81M | Perf YTD | 69.93% |
| Book/sh | 32.82 | P/C | 18.67 | EPS next 5Y | — | ROE | -3.59% | 52W High | 223.50 -0.63% | Perf Year | 68.59% |
| Cash/sh | 11.90 | P/FCF | — | EPS past 3/5Y | — | ROIC | -2.85% | 52W Low | 115.51 92.28% | Perf 3Y | 132.03% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | -8.48% 8.97% | Gross Margin | 59.90% | Volatility | 0.44% 0.37% | Perf 5Y | 44.75% |
| Dividend TTM | — | EV/Sales | 8.19 | EPS Y/Y TTM | — | Oper. Margin | -3.76% | ATR (14) | 0.90 | Perf 10Y | 277.72% |
| Dividend Ex-Date | — | Quick Ratio | 4.41 | Sales Y/Y TTM | 21.76% | Profit Margin | -4.57% | RSI (14) | 58.20 | Recom | 2.37 |
| Dividend Gr. 3/5Y | — | Current Ratio | 5.41 | EPS Q/Q | 545.45% | SMA20 | 0.22% | Beta | 1.19 | Target Price | 183.40 |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | 18.13% | SMA50 | 0.57% | Rel Volume | 1.55 | Prev Close | 222.45 |
| Employees | 1,930 | LT Debt/Eq | 0.00 | Earnings | Nov 03 | SMA200 | 5.13% | Avg Volume | 295.55K | Price | 222.10 |
| IPO Date | Mar 24, 2000 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.92% 0.09% | Net Debt/EBITDA | -198.50 | Volume | 458,677 | Change | -0.16% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Feb-06-26 | Reiterated | Morgan Stanley | Equal Weight | $147 → $231 |
| Feb-05-26 | Reiterated | UBS | Buy | $160 → $205 |
| Feb-05-26 | Reiterated | Barclays | Equal Weight | $130 → $231 |
| Feb-04-26 | Reiterated | Stifel Nicolaus | Buy | $165 → $231 |
| Feb-04-26 | Downgrade | Benchmark | Buy → Hold | |
| Feb-04-26 | Downgrade | Keybanc | Overweight → Sector Weight | |
| Feb-04-26 | Downgrade | Needham | Buy → Hold | |
| Jan-14-26 | Initiated | RBC Capital | Sector Perform | $160 |
| Oct-06-25 | Reiterated | Stifel Nicolaus | Buy | $160 → $165 |
| Aug-05-25 | Reiterated | Barclays | Equal Weight | $100 → $130 |
Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering and agriculture, smart street lighting, renewable energy, electric vehicle supply equipment, industrial wearables and equipment, commercial building automation, consumer electronics, asset tracking, and medical instrumentation; and commercial IoT applications, including smart buildings and lighting, access controls, asset tracking, electronic shelf labels, theft protection, power tools, and enterprise access points. The company’s smart home applications comprise smart home cameras, locks, gateways, residential lighting, window shades/blinds, heating, ventilation, air conditioning, switches, smoke/CO detectors, sensors, and home security panels; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking, as well as provides wireless microcontrollers products. It sells its products through its direct sales force, as well as a network of independent sales representatives and distributors. The company was founded in 1996 and is headquartered in Austin, Texas.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 1/3/2026 | FY 2024 12/28/2024 | FY 2023 12/30/2023 | FY 2022 12/31/2022 | FY 2021 1/1/2022 | FY 2020 1/2/2021 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 856 | 785 | 584 | 782 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 344 | 328 | 272 | 322 | — | — | — | — | — | |
| Gross Profit | 513 | 457 | 312 | 461 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 190 | 174 | 145 | 147 | — | — | — | — | — | |
| Research and Development | 356 | 353 | 332 | 338 | — | — | — | — | — | |
| Other Operating Expense | -2 | 1 | 1 | 0 | — | — | — | — | — | |
| Operating Income | -32 | -71 | -165 | -24 | — | — | — | — | — | |
| Interest Expense | 0 | 1 | 1 | 6 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 14 | 12 | 3 | — | — | — | — | — | |
| Net Income Before Taxes | -33 | -58 | -155 | -27 | — | — | — | — | — | |
| Income Taxes | 6 | 7 | 36 | 8 | — | — | — | — | — | |
| Consolidated Net Income | -40 | -65 | -191 | -35 | — | — | — | — | — | |
| Net Income From Continuing Operations | -40 | -65 | -191 | -35 | — | — | — | — | — | |
| Net Income | -40 | -65 | -191 | -35 | — | — | — | — | — | |
| EPS (Recurring) | -1.18 | -1.98 | -5.93 | -1.09 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -1.18 | -1.98 | -5.93 | -1.09 | — | — | — | — | — | |
| EPS (Diluted) | -1.18 | -1.98 | -5.93 | -1.09 | — | — | — | — | — | |
| EBITDA | 2 | -19 | -105 | 46 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 8.56 | 5.55 | 7.00 | 5.41 | — | — | — | — | — | |
| Gross Margin | 59.93 | 58.22 | 53.42 | 58.95 | — | — | — | — | — | |
| Operating Margin | -3.74 | -9.04 | -28.25 | -3.07 | — | — | — | — | — | |
| Net Margin | -4.67 | -8.28 | -32.71 | -4.48 | — | — | — | — | — | |
| Shares Outstanding | 33 | 33 | 32 | 32 | — | — | — | — | — | |
| Market Capitalization | 7,329 | 4,354 | 4,089 | 4,233 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CONRAD ROBERT J | Sr VP and General Manager | Aug 14 '26 | Sale | 218.21 | 6,581 | 1,436,040 | 23,815 | Aug 17 |
| Johnson Robert Matthew | President & CEO | May 18 '26 | Sale | 216.83 | 8,024 | 1,739,844 | 80,519 | May 19 |
| Richardson Nina | Director | Jan 13 '26 | Sale | 149.00 | 1,355 | 201,895 | 8,543 | Jan 15 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Dec 05 '25 | Sale | 141.49 | 1,954 | 276,471 | 62,381 | Dec 08 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Dec 05 '25 | Option Exercise | 43.82 | 1,954 | 85,624 | 64,335 | Dec 08 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Dec 04 '25 | Option Exercise | 43.82 | 4,246 | 186,060 | 66,627 | Dec 08 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Dec 04 '25 | Sale | 140.17 | 4,246 | 595,162 | 62,381 | Dec 08 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 29 '25 | Option Exercise | 43.82 | 1,800 | 78,876 | 64,128 | Sep 02 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 29 '25 | Sale | 133.57 | 1,800 | 240,426 | 62,328 | Sep 02 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 22 '25 | Option Exercise | 43.82 | 8,000 | 350,560 | 70,328 | Aug 25 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 22 '25 | Sale | 145.23 | 8,000 | 1,161,840 | 62,328 | Aug 25 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 19 '25 | Option Exercise | 43.82 | 2,270 | 99,472 | 64,598 | Aug 20 |
| Tolany Brandon | Sr VP WW Sales & Marketing | Aug 19 '25 | Sale | 132.69 | 2,270 | 301,206 | 62,328 | Aug 20 |
| CONRAD ROBERT J | Sr VP and General Manager | May 16 '25 | Sale | 131.20 | 4,029 | 528,605 | 25,380 | May 19 |
| Johnson Robert Matthew | President & CEO | May 16 '25 | Sale | 131.20 | 5,879 | 771,325 | 73,688 | May 19 |